包含基因检测的人工耳蜗植入效果综合预测模型
该研究回顾性分析了2008年5月至2020年12月单中心203例人工耳蜗植入并接受基因检测患者的病历与影像,发现117例(57.6%)检出致病性遗传变异;致病性变异与婴儿组更优的耳蜗植入效果显著相关(β=0.23,95%CI 0.01至0.47,p=0.044),但在儿童组和成人组无显著关联;在无耳蜗畸形的遗传确诊儿童组中,累及螺旋神经节的遗传变异为不良预后因素(β=-57.24,95%CI -90.63至-23.75,p=0.004)。
要点
- 203例中117例(57.6%)检出致病性遗传变异。
- 致病性变异与婴儿组更优植入效果相关(β=0.23,p=0.044)。
- 儿童组和成人组中该关联无显著差异。
核心结论
- 已知的听力损失遗传病因与婴儿组更优的人工耳蜗植入效果相关,但在儿童组和成人组中无显著关联。
- 在无耳蜗畸形的遗传确诊儿童亚组中,累及螺旋神经节的遗传变异为不良预后因素。
- 作者认为人工耳蜗植入前应进行细致的遗传咨询。
研究设计与样本
- 回顾性研究,纳入2008年5月至2020年12月单家三级医疗机构接受人工耳蜗植入和基因检测的患者。
- 排除言语测试结果不可用及因感染或装置故障等并发症取出植入体的患者后,共纳入203例。
- 参与者分为成人组(≥19岁)、儿童组(2-18岁)和婴儿组(<24个月)。
主要发现
- 203例中117例(57.6%)检出致病性遗传变异。
- 致病性变异与婴儿组更优的耳蜗植入效果显著相关(β=0.23;95%CI 0.01至0.47;p=0.044),但在儿童组和成人组中无显著关联。
- 在无耳蜗畸形的遗传确诊患者中,累及螺旋神经节的遗传变异在儿童组为不良预后因素(β=-57.24;95%CI -90.63至-23.75;p=0.004)。
关键数值与推荐
- 结局指标包括听觉感知类别、单音节、双音节和句子评分。
- 婴儿组使用婴幼儿有意义听觉整合量表评分。
临床怎么用
- 作者认为人工耳蜗植入前应进行细致的遗传咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Despite growing interest in the genetic contribution to cochlear implant (CI) outcomes, only a few studies with limited samples have examined the association of CI outcomes with genetic etiologies. We analyzed CI outcomes using known predictors and genetic testing results to obtain a comprehensive understanding of the impact of genetic etiologies. DESIGN: We retrospectively reviewed the medical records and images of patients who underwent cochlear implantation and genetic testing at a single tertiary medical institution, between May 2008 and December 2020. After excluding those whose speech test results were unavailable, and those in whom the implant was removed due to complications, such as infection or device failure, 203 patients were included in this study. The participants were categorized into adult (≥19 years), child (2-18 years), and infant (<24 months) groups. Outcomes were measured based on categories of auditory perception, monosyllable, disyllable, and sentence scores. For the infant group, the Infant-Toddler Meaningful Auditory Integration Scale score was used. RESULTS: Among the 203 participants, a causative genetic variant was identified in 117 (57.6%) individuals. The presence of a causative variant was significantly associated with better CI outcomes in the infant group (β = 0.23; 95% confidence interval, 0.01 to 0.47; p = 0.044), but not in the child and adult groups. In the genetically confirmed patients without cochlear malformation, genetic variants involving the spiral ganglion was a poor prognostic factor in the child group (β = -57.24; 95% confidence interval, -90.63 to -23.75; p = 0.004). CONCLUSIONS: The presence of known genetic etiology of hearing loss was associated with better CI outcomes in the infant group, but not in the child and adult groups. A neural-type genetic variant was a poor prognostic factor in the genetically diagnosed child subgroup without cochlear malformation. Careful genetic counseling should be performed before cochlear implantation.
引用
- Han JH, Kim SH, Moon IS, et al. Comprehensive Prediction Model, Including Genetic Testing, for the Outcomes of Cochlear Implantation. Ear Hear. 2022. PMID: 35973050. doi:10.1097/AUD.0000000000001269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。